Notice: McGill researchers receive $7M to fight brain diseases of aging


The Weston Brain Institute awards over $30 million nationally for high-risk, high-reward translational research projects to help speed up the development of treatments for neurodegenerative diseases of aging. The Institute is Canada’s largest privately funded national initiative aimed at accelerating breakthrough discoveries for the treatment of neurodegenerative diseases of aging, including Alzheimer’s, Parkinson’s and frontotemporal dementia.

Of the researchers that received funding, there is Dr. Marta Kaminska (Assistant Professor, Department of Medicine/ RI-MUHC), who focuses on respiratory issues, particularly sleep-related breathing disorders, in neurological diseases such as Parkinson’s disease (PD). With the funding from the Weston Institute, she will be examining the effects of long-acting levodopa (a chemical precursor of dopamine and a standard PD treatment) on obstructive sleep apnea in PD patients in a pilot proof-of-concept trial.

Congratulations and best of luck to all the recipients!